| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |